Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence

This study uses artificial intelligence (AI) combined with multi-omics data (genetic, protein, and other biological markers) from breast cancer tissue and blood samples to build a model that predicts which patients are at risk of their breast cancer spreading to distant organs such as the liver, bone, lung, or brain. **You may be eligible if...** - You are a female patient with a pathological diagnosis of breast cancer - Your diagnosis occurred at a participating hospital between January 2000 and December 2028 - You have developed distant metastases (spread to liver, bone, lung, or brain), AND your tissue samples from the primary tumor or metastatic site are stored at the participating hospital - Complete clinical information is available **You may NOT be eligible if...** - You have a metastatic cancer from a different primary origin (not breast cancer) - Your clinical information is incomplete Talk to your doctor to see if this trial is right for you.